These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 27255389)

  • 21. How to modulate gut microbiota: diet, preprobiotics or antibiotics?
    Ponziani FR; Binda C; Gasbarrini A
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):411-419. PubMed ID: 28215066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery.
    Guo Y; Huang ZP; Liu CQ; Qi L; Sheng Y; Zou DJ
    Eur J Endocrinol; 2018 Jan; 178(1):43-56. PubMed ID: 28916564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bifidobacterium adolescentis IM38 ameliorates high-fat diet-induced colitis in mice by inhibiting NF-κB activation and lipopolysaccharide production by gut microbiota.
    Lim SM; Kim DH
    Nutr Res; 2017 May; 41():86-96. PubMed ID: 28479226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut Microbiota and Obesity: A Role for Probiotics.
    Abenavoli L; Scarpellini E; Colica C; Boccuto L; Salehi B; Sharifi-Rad J; Aiello V; Romano B; De Lorenzo A; Izzo AA; Capasso R
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption.
    Damms-Machado A; Mitra S; Schollenberger AE; Kramer KM; Meile T; Königsrainer A; Huson DH; Bischoff SC
    Biomed Res Int; 2015; 2015():806248. PubMed ID: 25710027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiological role of host microbiota in the development of obesity.
    Kobyliak N; Virchenko O; Falalyeyeva T
    Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements.
    Sivamaruthi BS; Kesika P; Suganthy N; Chaiyasut C
    Biomed Res Int; 2019; 2019():3291367. PubMed ID: 31211135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats.
    Etxeberria U; Arias N; Boqué N; Macarulla MT; Portillo MP; Martínez JA; Milagro FI
    J Nutr Biochem; 2015 Jun; 26(6):651-60. PubMed ID: 25762527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota: a target for intervention in obesity.
    Sehgal K; Khanna S
    Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota and obesity.
    Gérard P
    Cell Mol Life Sci; 2016 Jan; 73(1):147-62. PubMed ID: 26459447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High fat diet drives obesity regardless the composition of gut microbiota in mice.
    Rabot S; Membrez M; Blancher F; Berger B; Moine D; Krause L; Bibiloni R; Bruneau A; Gérard P; Siddharth J; Lauber CL; Chou CJ
    Sci Rep; 2016 Aug; 6():32484. PubMed ID: 27577172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gut microbiota as a therapeutic target for obesity: a scoping review.
    Santos-Paulo S; Costello SP; Forster SC; Travis SP; Bryant RV
    Nutr Res Rev; 2022 Dec; 35(2):207-220. PubMed ID: 34100344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the normal gut microbiota.
    Jandhyala SM; Talukdar R; Subramanyam C; Vuyyuru H; Sasikala M; Nageshwar Reddy D
    World J Gastroenterol; 2015 Aug; 21(29):8787-803. PubMed ID: 26269668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity.
    Hwang I; Park YJ; Kim YR; Kim YN; Ka S; Lee HY; Seong JK; Seok YJ; Kim JB
    FASEB J; 2015 Jun; 29(6):2397-411. PubMed ID: 25713030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The microbiome and obesity: is obesity linked to our gut flora?
    Tsai F; Coyle WJ
    Curr Gastroenterol Rep; 2009 Aug; 11(4):307-13. PubMed ID: 19615307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.